TrialPanorama/TrialPanorama-database huggingface dataset:
Study: NCT05892016

Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Alveolar ridge preservation
Description: grafted with bone particle and covered with a subepithelial connective tissue graft

Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Alveolar ridge preservation
Description: grafted with bone particle and covered with a subepithelial connective tissue graft

Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Alveolar ridge preservation
Description: grafted with bone particle and covered with a subepithelial connective tissue graft

Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Alveolar ridge preservation
Description: grafted with bone particle and covered with a subepithelial connective tissue graft

Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Alveolar ridge preservation
Description: grafted with bone particle and covered with vascularized interpositional periosteal connective tissue graft

Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Alveolar ridge preservation
Description: grafted with bone particle and covered with vascularized interpositional periosteal connective tissue graft

Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Alveolar ridge preservation
Description: grafted with bone particle and covered with vascularized interpositional periosteal connective tissue graft

Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Alveolar ridge preservation
Description: grafted with bone particle and covered with vascularized interpositional periosteal connective tissue graft

Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Alveolar ridge preservation
Description: grafted with bone particle and covered with a collagen membrane

Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Alveolar ridge preservation
Description: grafted with bone particle and covered with a collagen membrane

Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Alveolar ridge preservation
Description: grafted with bone particle and covered with a collagen membrane

Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Alveolar ridge preservation
Description: grafted with bone particle and covered with a collagen membrane

Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Alveolar ridge preservation
Description: grafted with bone particle and covered with a Cytoplast

Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Alveolar ridge preservation
Description: grafted with bone particle and covered with a Cytoplast

Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Alveolar ridge preservation
Description: grafted with bone particle and covered with a Cytoplast

Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Alveolar ridge preservation
Description: grafted with bone particle and covered with a Cytoplast
Study: NCT05231655

Intervention type: DIAGNOSTIC_TEST
Intervention: Functional drug screen
Description: High-throughput ex-vivo drug screen of cells processed directly from solid tumours to determine sensitivity / resistance profiles

Intervention type: DIAGNOSTIC_TEST
Intervention: Functional drug screen
Description: High-throughput ex-vivo drug screen of cells processed directly from solid tumours to determine sensitivity / resistance profiles

Intervention type: DIAGNOSTIC_TEST
Intervention: Functional drug screen
Description: High-throughput ex-vivo drug screen of cells processed directly from solid tumours to determine sensitivity / resistance profiles

Intervention type: DIAGNOSTIC_TEST
Intervention: Functional drug screen
Description: High-throughput ex-vivo drug screen of cells processed directly from solid tumours to determine sensitivity / resistance profiles

Intervention type: DIAGNOSTIC_TEST
Intervention: Functional drug screen
Description: High-throughput ex-vivo drug screen of cells processed directly from solid tumours to determine sensitivity / resistance profiles

Intervention type: DIAGNOSTIC_TEST
Intervention: Functional drug screen
Description: High-throughput ex-vivo drug screen of cells processed directly from solid tumours to determine sensitivity / resistance profiles
Study: NCT04930003

Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: QazCoVac-P -COVID-19 Subunit Vaccine
Description: QazCoVac-P (Subunit) Vaccine manufactured by Research Institute for Biological Safety Problems Republic of Kazakhstan

Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: QazCoVac-P -COVID-19 Subunit Vaccine
Description: QazCoVac-P (Subunit) Vaccine manufactured by Research Institute for Biological Safety Problems Republic of Kazakhstan

Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: QazCoVac-P -COVID-19 Subunit Vaccine
Description: QazCoVac-P (Subunit) Vaccine manufactured by Research Institute for Biological Safety Problems Republic of Kazakhstan

Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: QazCoVac-P -COVID-19 Subunit Vaccine
Description: QazCoVac-P (Subunit) Vaccine manufactured by Research Institute for Biological Safety Problems Republic of Kazakhstan

Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: QazCoVac-P -COVID-19 Subunit Vaccine
Description: QazCoVac-P (Subunit) Vaccine manufactured by Research Institute for Biological Safety Problems Republic of Kazakhstan

Intervention type: OTHER
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: The use of placebo: intramuscularly, twice, spaced 21 days apart, at a dose of 0.5 ml (22 volunteers)
Study: NCT06250088

Intervention type: BIOLOGICAL
Group type: ACTIVE_COMPARATOR
Intervention: Emdogain (EMD) - test
Description: Initially, tooth sectioning of the hopeless tooth (receptor) will be carried out using fissure carbide burs, and the resulting fragments will be extracted with a minimally invasive approach. A multiple drilling axis tooth-supported surgical guide will be used to prepare the recipient site in accordance with the 3D planning. Additional alveoloplasty procedures will be performed with round diamond burs if necessary to adapt the computer assisted rapid prototyping (CARP) model to the virtual planning position. The donor tooth will be extracted as atraumatically as possible, utilizing a piezoelectric if ostectomy is required, and avoiding the use of elevators or forceps over the root surface. Extraorally, (Emdogain) EMD will be applied to the root surface of the donor tooth. Sutures will be applied to closely adapt the soft tissues around the autotransplanted tooth. A semi-rigid orthodontic wire will be used to splint the tooth to the mesial and distal adjacent teeth

Intervention type: PROCEDURE
Group type: SHAM_COMPARATOR
Intervention: Sham group
Description: Initially, tooth sectioning of the hopeless tooth (receptor) will be carried out using fissure carbide burs, and the resulting two fragments will be extracted with a minimally invasive approach. A multiple drilling axis tooth-supported surgical guide will be used to prepare the recipient site in accordance with the 3D planning. Additional alveoloplasty procedures will be performed with round diamond burs if necessary to adapt thecomputer assisted rapid prototyping (CARP) model to the virtual planning position. The donor tooth will be extracted as atraumatically as possible, utilizing a piezoelectric surgical instrument if ostectomy is required, and avoiding the use of elevators or forceps over the root surface. No Emdodain (EMD). Sutures will be applied to closely adapt the soft tissues around the autotransplanted tooth. A semi-rigid orthodontic wire will be used to splint the tooth to the mesial and distal adjacent teeth

Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Sham group
Description: Initially, tooth sectioning of the hopeless tooth (receptor) will be carried out using fissure carbide burs, and the resulting two fragments will be extracted with a minimally invasive approach. A multiple drilling axis tooth-supported surgical guide will be used to prepare the recipient site in accordance with the 3D planning. Additional alveoloplasty procedures will be performed with round diamond burs if necessary to adapt thecomputer assisted rapid prototyping (CARP) model to the virtual planning position. The donor tooth will be extracted as atraumatically as possible, utilizing a piezoelectric surgical instrument if ostectomy is required, and avoiding the use of elevators or forceps over the root surface. No Emdodain (EMD). Sutures will be applied to closely adapt the soft tissues around the autotransplanted tooth. A semi-rigid orthodontic wire will be used to splint the tooth to the mesial and distal adjacent teeth
Study: NCT05885269

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Group A applied topical Clobetasol Propionate
Description: Patient in group-A applied clobetasol propionate 0.05% twice daily for upto 03 months

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Group B applied topical Tacrolimus
Description: Group-B applied topical tacrolimus 0.1% twice daily for upto 3 months.
Study: NCT06385613

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Mobile-based stoma care education group
Description: Individuals included in the intervention group will be given mobile-based stoma care trainings before surgery, on the 3rd postoperative day, on the day of discharge, and on the 1st and 3rd months after discharge, and their effectiveness will be measured using data collection forms.

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Mobile-based stoma care education group
Description: Individuals included in the intervention group will be given mobile-based stoma care trainings before surgery, on the 3rd postoperative day, on the day of discharge, and on the 1st and 3rd months after discharge, and their effectiveness will be measured using data collection forms.
Study: NCT05787145

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Let's Discuss Health Group
Description: Use of the Let's Discuss Health website to prepare four medical encounters with the radiation oncologist throughout the radiation care trajectory.
Study: NCT06483386

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Pyrotinib and Subcutaneous preparation of trastuzumab combined with capecitabine
Description: Pyrotinib and Subcutaneous preparation of trastuzumab combined with capecitabine
Study: NCT04833426

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Testosterone gel
Description: Topical gel containing testosterone

Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: Topical gel without active substance
Study: NCT00290381

Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Oxagen OC000459

Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Oxagen OC000459
Study: NCT05039320

Intervention type: DIETARY_SUPPLEMENT
Group type: EXPERIMENTAL
Intervention: Bactoblis
Description: dissolve the tablets in the mouth once a day for 4 weeks

Intervention type: DIETARY_SUPPLEMENT
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: dissolve the tablets in the mouth once a day for 4 weeks
Study: NCT05180370

Intervention type: OTHER
Intervention: Questionnaies
Description: Data entry staff who will be assigned to the centers for 2 weeks will apply a questionnaire consisting of different questions to the patients referred to them by clinicians with the diagnosis of HF (presented in the appendix to this protocol). In addition, Pittsburg Sleep Quality Index will be applied to all cases.
Study: NCT06134583

Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Superior cervical sympathetic block group
Description: 5 ml bupivacaine 0.5% will be injected around the internal carotid artery at the level of carotid bifurcation

Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Stellate ganglion block group
Description: 5 ml bupivacaine 0.5% will be injected between the common carotid artery and longus capitis muscle at the level of C7 vertebra
Study: NCT05707715

Intervention type: DEVICE
Intervention: XSensor
Description: A pressure mapping system (X3 SENSOR PX 100:64.160.02, X-Sensor®, Calgary, Canada) was used to record the pressure distribution in mmHg of the head and shoulder section \[18,19\]. Pressure distribution was recorded for 1 minute for each lying position. The purpose of these measurements was to describe the pressure distribution created by the participants in the pillow and the supported areas, as well as to find out the differences that may occur between the pillows. Lower pressure values measured by the device were defined as high comfort, while more contact of the head area with the pillow was accepted as high support.

Intervention type: DEVICE
Intervention: XSensor
Description: A pressure mapping system (X3 SENSOR PX 100:64.160.02, X-Sensor®, Calgary, Canada) was used to record the pressure distribution in mmHg of the head and shoulder section \[18,19\]. Pressure distribution was recorded for 1 minute for each lying position. The purpose of these measurements was to describe the pressure distribution created by the participants in the pillow and the supported areas, as well as to find out the differences that may occur between the pillows. Lower pressure values measured by the device were defined as high comfort, while more contact of the head area with the pillow was accepted as high support.
Study: NCT04838964

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: MRG003
Description: Administrated intravenously
Study: NCT06172998

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Phentolamine Injection
Description: Under patient safety, Phentolamine will be pumped into the OSA patients equipped with PSG and ECG monitoring in a safe dose to prevent sympathetic overactivity. Under patient safety, Nitroglycerin will be pumped into the OSA patients equipped with PSG and ECG monitoring in a safe dose to prevent endothelial dysfunction.
Study: NCT04912700

Intervention type: BIOLOGICAL
Intervention: COVID-19 vaccine
Description: Full or partial reception of vaccine

Intervention type: BIOLOGICAL
Intervention: COVID-19 vaccine
Description: Full or partial reception of vaccine
Study: NCT05849571

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: coconut oil
Description: • The patient's mouth is evaluated using the World Health Organization Mucositis Classification and the International Child Mucositis Evaluation Scale (ChIMES) on days 0, 7, and 14, and after each assessment, the frequency of oral care is determined and applied for 21 days. The final assessment is made on Day 21.
Study: NCT04747821

Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: Adsorbed COVID-19 (Inactivated) Vaccine
Description: Adsorbed COVID-19 (inactivated) Vaccine manufactured by Sinovac

Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: Adsorbed COVID-19 (Inactivated) Vaccine
Description: Adsorbed COVID-19 (inactivated) Vaccine manufactured by Sinovac

Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: Adsorbed COVID-19 (Inactivated) Vaccine
Description: Adsorbed COVID-19 (inactivated) Vaccine manufactured by Sinovac

Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: Adsorbed COVID-19 (Inactivated) Vaccine
Description: Adsorbed COVID-19 (inactivated) Vaccine manufactured by Sinovac
Study: NCT04662294

Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: CD70 CAR T-cells
Description: Each subject receive CD70 CAR T-cells by intravenous infusion

Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: CD70 CAR T-cells
Description: Each subject receive CD70 CAR T-cells by intravenous infusion

Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: CD70 CAR T-cells
Description: Each subject receive CD70 CAR T-cells by intravenous infusion
Study: NCT05426109

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Peanut snacks
Description: Participants will undergo a 10-week diet and weight training regimen to promote healthy weight gain. These participants will receive seven 500 kcal peanut-containing (whole peanuts or peanut butter) snacks each week and consume one snack per day throughout the study. They will also perform a series of weight training exercises supervised by a personal trainer on 3 days per week.

Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: No peanut-containing snacks
Description: Participants will undergo a 10-week diet and weight training regimen to promote healthy weight gain. These participants will receive seven 500 kcal non-peanut-containing high carbohydrate snacks each week and consume one snack per day throughout the study. They will also perform a series of weight training exercises supervised by a personal trainer on 3 days per week.
Study: NCT06333405

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Fecal Microbiota Transplantation
Description: Procedure: Fecal Microbiota Transplantation~Fecal Microbiota as a suspension obtained from healthy unrelated donor (woman in 3rd trimester of pregnancy) introduced two times per treatment:~* as a deep rectal infusion, via Foley's catheter inserted under ultrasound control, twice 6 hours apart, between 3 and 6 days after birth and/or up to 14 days~* Other Names: MBiotix HBI
Study: NCT04812795

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Culturally tailored anti-smoking messages
Description: Anti-smoking messages that are culturally tailored for sexual minority women.

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Culturally tailored anti-smoking messages
Description: Anti-smoking messages that are culturally tailored for sexual minority women.

Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Non-culturally tailored interventions
Description: Anti-smoking messages that are not culturally tailored for sexual minority women.

Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Non-culturally tailored interventions
Description: Anti-smoking messages that are not culturally tailored for sexual minority women.
Study: NCT04742309

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Pecs-2 block (single injection)
Description: For Pecs-2 blocks, the needle will be advanced to the tissue plane between the pectoralis major and minor muscles at the vicinity of the pectoral branch of the acromiothoracic artery where 10 mL of local anesthetic will be deposited. In a similar manner, 20 mL will be deposited at the level of the third rib above the serratus anterior muscle with the intent of spreading injectate to the axilla. The study fluid will be ropivacaine 0.3% with epinephrine.

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Paravertebral block (single injection)
Description: For paravertebral blocks, ropivacaine 0.5% (with epinephrine) 9 mL will be administered at each of two levels per side: the T3 and T5 levels for sides without axillary involvement; and at the T2 and T4 level for sides with axillary involvement.
Study: NCT04633902

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Olaparib
Description: Olaparib 300 mg BID daily

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Pembrolizumab
Description: Pembrolizumab 200 mg IV eveyr 3 weeks (for up to 2 years)
Study: NCT06114498

Intervention type: DIAGNOSTIC_TEST
Intervention: Echocardiography
Description: Transthoracic echocardiography at rest: with determination of epicardial fat tissue thickness, intensity of mitral regurgitation.

Intervention type: DIAGNOSTIC_TEST
Intervention: Bioimpedance
Description: Bioelectrical impedance analysis research

Intervention type: DIAGNOSTIC_TEST
Intervention: Bioimpedance
Description: Bioelectrical impedance analysis research

Intervention type: DIAGNOSTIC_TEST
Intervention: Immunoassay
Description: Enzyme immunoassay of heat shock proteins in blood serum

Intervention type: DIAGNOSTIC_TEST
Intervention: Immunoassay
Description: Enzyme immunoassay of heat shock proteins in blood serum

Intervention type: DIAGNOSTIC_TEST
Intervention: Routine biochemistry
Description: Measuring of routine biochemical parameters (glucose, total protein, creatinine, urea, uric acid, total bilirubin, direct bilirubin, total cholesterol, triglycerides, low and high density lipoprotein cholesterol, Lactate dehydrogenase, creatine phosphokinase, aspartate aminotransferase, alanine aminotransferase, sodium, potassium and special (C-reactive protein, N-terminal pro b-type natriuretic peptide)

Intervention type: DIAGNOSTIC_TEST
Intervention: Routine biochemistry
Description: Measuring of routine biochemical parameters (glucose, total protein, creatinine, urea, uric acid, total bilirubin, direct bilirubin, total cholesterol, triglycerides, low and high density lipoprotein cholesterol, Lactate dehydrogenase, creatine phosphokinase, aspartate aminotransferase, alanine aminotransferase, sodium, potassium and special (C-reactive protein, N-terminal pro b-type natriuretic peptide)
Study: NCT06370338

Intervention type: OTHER
Intervention: Delphi Questionnaire
Description: Experts will be approached to participate in the research via email. If the experts agree to participate they will check 'yes' in the email with the informed consent and will be directed to the Qualtrics survey. If the expert decides to decline consent they will check 'no' in the email and will not be enrolled. Subjects who agree to participate will undergo 2 phases of questions with three rounds of the same questions in each phase. This Delphi survey research involves Phase 1 and Phase 2 of questioning, each phase involves up to 3 rounds of questions to determine agreement or disagreement. Each round will take approximately 20 minutes to complete, and your responses will remain completely confidential. For both phases, the questions will either be 7-point Likert or multiple choices. For both phases, the group of questions will be sent up to three times until we obtain agreement (up to 80% of agreement consensus). Questions that have obtained agreement will be removed in each round.
Study: NCT05287334

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Electrical impedance tomography measurement
Description: During standard blood donation, donors' chest bioimpedance will be measured using electrical impedance tomography.
Study: NCT06152744

Intervention type: OTHER
Intervention: Monitoring membrane lung function at different altitudes
Description: The altitude in Beijing is 100m, while the altitude in Xining, Qinghai is 2600m. We will monitor the partial pressure of post-ML arterial oxygen in ECMO patients in these two locations and evaluate whether the normal values of membrane lung function are consistent in different altitudes.

Intervention type: OTHER
Intervention: Monitoring membrane lung function at different altitudes
Description: The altitude in Beijing is 100m, while the altitude in Xining, Qinghai is 2600m. We will monitor the partial pressure of post-ML arterial oxygen in ECMO patients in these two locations and evaluate whether the normal values of membrane lung function are consistent in different altitudes.
Study: NCT05983575

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: LIPUS-Brain
Description: Transcranial low-power pulsed-wave ultrasound device

Intervention type: DEVICE
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: Placebo